Nasa is sending these experiments to space in November
T he uncrewed SpaceX Dragon spacecraft will carry several projects to the International Space Station (ISS) from NASA’s Kennedy Space Center in Florida.
Nasa is set to launch a series of scientific experiments and technology demonstrations on the SpaceX commercial resupply services (CRS) mission
The uncrewed SpaceX Dragon spacecraft will carry several projects to the International Space Station (ISS) from Nasa’s Kennedy Space Center in Florida.One of the key investigations is Nasa's ILLUMA-T, which aims to test enhanced data communication capabilities on the ISS.This technology demonstration involves a terminal mounted on the station's exterior that uses laser or optical communications to send high-resolution information to Nasa's Laser Communications Relay Demonstration (LCRD) system, which is in geosynchronous orbit around Earth.
Our Newsletter
Subscribe our newsletter to get latest news & promotion
By subscribing, you accepted the our Policy
The ILLUMA-T investigation is expected to pave the way for placing laser communications terminals on spacecraft orbiting the Moon or Mars.
Another notable experiment scheduled for the CRS-29 mission is the Atmospheric Waves Experiment (AWE). This initiative will utilize an infrared imaging instrument to assess the properties, distribution, and dynamics of atmospheric gravity waves (AGWs).
AGWs are disturbances that traverse Earth's atmosphere, akin to ripples formed by a stone dropped into water. The AWE research endeavor holds the potential to enhance our comprehension of AGWs and contribute to a deeper understanding of Earth's atmosphere, its impact on weather patterns, and its role in climate dynamics. Beyond these primary projects, the CRS-29 mission will encompass additional research, such as investigations into the impact of stress on ovulation and bone health, the testing of novel water recovery systems for the ISS, and an exploration into how the mucus lining in the respiratory system influences the delivery of pharmaceuticals.